Skip to main content

Table 4 Hematologic test before the first cycle of NACT for ESCC

From: Clinical value of hematologic test in predicting tumor response to neoadjuvant chemotherapy with esophageal squamous cell carcinoma

 

CR + PR

SD + PD

P value

WBC (*109/L)

6.80 ± 1.85

8.42 ± 1.10

0.003

Lym% (%)

26.28 ± 8.49

20.50 ± 6.86

0.047

MON# (*109/L)

0.40 ± 0.19

0.60 ± 0.23

0.027

NEUT# (*109/L)

4.54 ± 1.60

6.25 ± 1.40

0.005

EO# (*109/L)

0.08 ± 0.06

0.13 ± 0.05

0.038

ALT (U/L)

12.00 ± 3.99

18.00 ± 5.29

0.003

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us